Instructor in Pathology, Massachusetts General Hospital
Pathology
Dr. Adriano Piris, MD
|
|
Give Review
Doctor Adriano Piris, MD practices Pathology. Adriano Piris is a published doctor and has 42 publications published. The lastest was: 'Clear Cell Carcinoma of the Penis: An HPV-related Variant of Squamous Cell Carcinoma: A Report of 3 Cases.' Adriano Piris, MD accepts Medicare.
Publications
- Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients.
- BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
- Primary Mucosal Melanoma of the Sinonasal Tract: A Clinicopathologic and Immunohistochemical Study of Thirty-Two Cases.
- Extensive Squamous Cell Carcinoma of the Skin Related to Use of Sorafenib for Treatment of FLT3-Mutant Acute Myeloid Leukemia.
- p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases.
- Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade.
- Cutaneous and mammary apocrine carcinomas have different immunoprofiles.
- BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes.
- Case records of the Massachusetts General Hospital. Case 21-2013. A 68-year-old man with metastatic melanoma.
- TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF-Mutant Melanoma.
- Wolf isotopic response manifesting as postherpetic granuloma annulare: a case series.
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma.
- Melanoma staging: where are we now?
- Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families.
- Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic.
- EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib.
- RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors.
- Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases.
- AJCC melanoma staging update: impact on dermatopathology practice and patient management.
- Primary subcutaneous Alternaria alternata infection of the hand in an immunocompromised host.
- Case records of the Massachusetts General Hospital. Case 35-2010. A 56-year-old man with cough, hypoxemia, and rash.
- Case records of the Massachusetts General Hospital. Case 30-2010. A 15-year-old boy with a recurrent skin lesion.
- Histologic processing and reporting of cutaneous pigmented lesions: recommendations based on a survey of 94 dermatopathologists.
- Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas.
- Global dermatopathology: Hansen''s disease--current concepts and challenges.
- Dynamic gene expression analysis links melanocyte growth arrest with nevogenesis.
- Case records of the Massachusetts General Hospital. Case 22-2009. A 59-year-old man with skin and pulmonary lesions after chemotherapy for leukemia [corrected].
- Progress in melanoma histopathology and diagnosis.
- Atypical and malignant hidradenomas: a histological and immunohistochemical study.
- NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients.
- Apocrine cystadenoma and apocrine hidrocystoma: examination of 21 cases with emphasis on nomenclature according to proliferative features.
- Mechanisms of metastasis: seed and soil.
- Molecular mechanisms of metastasis.
- A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic...
- Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.
- Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma.
- Pigmented lesions in unusual anatomic sites.
- Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin.
- Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
- Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.
- Clear Cell Carcinoma of the Penis: An HPV-related Variant of Squamous Cell Carcinoma: A Report of 3 Cases.
Schools
Faculty De Ciencias Medicas University Nat39l De Cordoba
Berkshire Med Center
Massachusetts General Hospital
Montefiore Med Center
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- GHI PPO
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Principal Life
- Simplifi
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Beth Israel Deaconess Medical Center -
Massachusetts General Hospital -
Universidad Nacional de Asuncion Faculty of Medicine
Hospital
-
Brigham and Women's Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1831293703 | |
| NPPES Provider LastName | PIRIS | |
| NPPES Provider FirstName | ADRIANO | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Pathology | |
| Total Claim Count | 203.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831293703 |
| Last Name Of The Provider | PIRIS |
| First Name Of The Provider | ADRIANO |
| View All |
Similar Doctors
|
|
Dr. Arthur G. Aaronson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melinda J. Lerwill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory Y. Lauwers, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert P. Hasserjian, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sarah Chiang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Atul K. Bhan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sacha N. Uljon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie Y. Tse, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerlinde Wernig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph W. Carlson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eleonora Galvanek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judith N. Robens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michiya Nishino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harold F. Dvorak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rita M. Addison, MD |